The Use of Metoprolol CR/XL in the Treatment of Patients with Diabetes and Chronic Heart Failure

References

• [AHA] American Heart AssociationHeart Disease and Stroke Statistics – 2005 Update2004DallasAHA
   Google Scholar
• AlmdalTScharlingHJensenJSThe independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13 000 men and women with 20 years of follow-upArch Intern Med20041641422615249351
   PubMed Web of Science ®Google Scholar
• AmitabhPMarkhamAMetoprolol: A review of its use in chronic heart failureDrugs2000606477811030472
   PubMed Web of Science ®Google Scholar
• AntonisAClarkMLHodgeRLReceptor mechanisms in the hyperglycaemic response to adrenaline in manLancet19671113574164792
   PubMed Web of Science ®Google Scholar
• ArvanSSingalBKnappRSubclinical left ventricular abnormalities in young diabeticsChest198893103143359822
   PubMed Web of Science ®Google Scholar
• BakrisGLFonsecaVKatholiREMetabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized, controlled trialJAMA200429222273615536109
   PubMed Web of Science ®Google Scholar
• BellDSHDiabetic CardiomyopathyDiabetes Care20032629495014514607
   PubMed Web of Science ®Google Scholar
• BellDSHLukasMAHoldbrookFThe effect of carvedilol on mortality risk in heart failure patients with diabetes: results of a meta-analysisCurr Med Res Opin2006222879616466600
   PubMed Web of Science ®Google Scholar
• BenfieldPClissoldSPBrogdenRNMetoprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in hypertension, ischaemic heart disease and related cardiovascular disordersDrugs1986313764292940080
   PubMed Web of Science ®Google Scholar
• BlackJWStephensonJSPharmacology of a new adrenergic betareceptor-blocking compound (nethalide)Lancet196223111413869657
   PubMed Web of Science ®Google Scholar
• CommunalCSinghKPimentelDRNorepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta-adrenergic pathwayCirculation1998981329349751683
   PubMed Web of Science ®Google Scholar
• CruickshankJMBeta-blocking agentsLancet1980114156104197
   PubMed Web of Science ®Google Scholar
• DargieHJLechatPThe Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trialLancet199935391310023943
   PubMed Web of Science ®Google Scholar
• DargieHJEffect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: The CAPRICORN Randomised TrialLancet200135713859011356434
   PubMed Web of Science ®Google Scholar
• DeaconSPBarnettDComparison of atenolol and propranolol during insulin-induced hypoglycemiaBMJ1976227238184
   PubMedGoogle Scholar
• DeedwaniaPCGilesTDKlibanerMEfficacy, safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: experiences from MERIT-HFAm Heart J20051491596715660048
   PubMed Web of Science ®Google Scholar
• Di LenardaARemmeWJCharlesworthAExchange of beta blockers in heart failure patients. Experience from the poststudy phase of COMET (the Carvedilol or Metoprolol European Trial)Eur J Heart Fail20057640915921806
   PubMed Web of Science ®Google Scholar
• FangZYPrinsJBMarwickTHDiabetic cardiomyopathy: evidence, mechanisms, and therapeutic implicationsEndocr Rev2004255436715294881
   PubMed Web of Science ®Google Scholar
• FischerVWBarnerHBLeskiwMLCapillary basal laminar thickness in diabetic human myocardiumDiabetes19792871319446928
   PubMed Web of Science ®Google Scholar
• GebhardtVAWisenbergGThe role of beta blockade, with and without intrinsic sympathomimetic activity, in preserving compromised left ventricular function in patients with ischemic heart diseaseAm Heart J19851091013202859772
   PubMed Web of Science ®Google Scholar
• GoldsteinSKennedyHLHallCMetoprolol CR/XL in patients with heart failure: a pilot study examining the tolerability, safety, and effect on left ventricular ejection fractionAm Heart J199913811586510577448
   PubMed Web of Science ®Google Scholar
• HaasSJVosTGilbertREAre-blockers as efficacious in patients with diabetes mellitus as in patients without diabetes mellitus who have chronic heart failure? A meta-analysis of large-scale clinical trialsAm Heart J20031468485314597934
   PubMed Web of Science ®Google Scholar
• HirschIBBoylePJCraftSHigher glycemic thresholds for symptoms during beta-adrenergic blockade in IDDMDiabetes1991401177861657673
   PubMed Web of Science ®Google Scholar
• HjalmarsonAGoldsteinSFagerbergBEffects of controlledrelease metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: The Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF)JAMA2000283129530210714728
   PubMed Web of Science ®Google Scholar
• HoKKPinskyJLKannelWBThe epidemiology of heart failure: the Framingham StudyJ Am Coll Cardiol Suppl1993226A13A
   PubMed Web of Science ®Google Scholar
• HoffmanBBLefkowitzRJGoodmanLSLimbirdLEMilinoffPBCatecholamines, Sympathomimetic Drugs, and Adrenergic Receptor AntagonistsThe pharmacological basis of therapeutics19969th editionNew YorkMcGraw-Hill199248
   Google Scholar
• HuntSAACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure)J Am Coll Cardiol200546e18216168273
   PubMed Web of Science ®Google Scholar
• IribarrenCKarterAJGoASGlycemic control and heart failure among adult patients with diabetesCirculation200110326687311390335
   PubMed Web of Science ®Google Scholar
• KannelWBHjortlandMCastelliWPRole of diabetes in congestive heart failure. The Framingham StudyAm J Cardiol19743429344835750
   PubMed Web of Science ®Google Scholar
• KannelWBMcGeeDLDiabetes and glucose tolerance as risk factors for cardiovascular disease: The Framingham StudyDiabetes Care197921206520114
   PubMedGoogle Scholar
• KaumannAJSandersLBoth beta 1-and beta 2-adrenoceptors mediate catecholamine-evoked arrhythmias in isolated human right atriumNaunyn Schmiedebergs Arch Pharmacol1993348536408114953
   PubMed Web of Science ®Google Scholar
• KnowltonKUMichelMCItaniMThe alpha 1A-adrenergic receptor subtype mediates biochemical, molecular, and morphologic features of cultured myocardial cell hypertrophyJ Biol Chem199326815374808393439
   PubMed Web of Science ®Google Scholar
• MarwickTHDiabetic heart diseaseHeart20069229630016159978
   PubMed Web of Science ®Google Scholar
• Molina-ViamonteVAnyukhovskyEPRosenMRAn alpha-1-adrenergic receptor subtype is responsible for delayed after depolarizations and triggered activity during simulated ischemia and reperfusion of isolated canine Purkinje fibersCirculation1991841732401680578
   PubMed Web of Science ®Google Scholar
• PackerMCoatsAJFowlerMEffect of carvedilol on survival in severe chronic heart failureN Engl J Med20013441651811386263
   PubMed Web of Science ®Google Scholar
• PolskerGLClissoldSPControlled release metoprolol formulations. A review of their pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and ischemic heart diseaseDrugs1992433824141374320
   PubMed Web of Science ®Google Scholar
• Poole-WilsonPASwedbergRClelandJGComparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trialLancet200336271312853193
   PubMed Web of Science ®Google Scholar
• PowellCESlaterIHBlocking of inhibitory adrenergic receptors by a dichloro analog of isoproterenolJ Pharmacol Exp Ther1958122480813539775
   PubMed Web of Science ®Google Scholar
• ReynoldsRDGorczynskiRJQuonCYPharmacology and pharmacokindetics of esmololJ Clin Pharmacol Suppl198626A1314
   Web of Science ®Google Scholar
• RevenoWSRosenbaumHPropranolol and hypoglycaemiaLancet196819204171519
   PubMed Web of Science ®Google Scholar
• RossenJDAbnormal microvascular function in diabetes: relationship to diabetic cardiomyopathyCoron Artery Dis1996713388813444
   PubMed Web of Science ®Google Scholar
• ShekellePGRichMWMortonSCEfficacy of angiotensinconverting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trialsJ Am Coll Cardiol20034115293812742294
   PubMed Web of Science ®Google Scholar
• ShorrRIRayWADaughertyJRAntihypertensives and the risk of serious hypoglycemia in older persons using insulin or sulfonylureasJAMA19972784039207336
   PubMed Web of Science ®Google Scholar
• StonePHMuellerJHartwellTThe effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and left ventricular dysfunction to the adverse prognosis. The MILIS Study GroupJ Am Coll Cardiol19891449572661630
   PubMed Web of Science ®Google Scholar
• SunDNguyenNDe GradoTRIschemia induces translocation of the insulin-responsive glucose transporter GLUT4 to the plasma membrane of cardiac myocytesCirculation19948979388313568
   PubMed Web of Science ®Google Scholar
• SundbergSGordinAInfluence of beta blockade and intrinsic sympathomimetic activity on hemodynamics, inotropy and respiration at rest and during exerciseAm J Cardiol198657139492872795
   PubMed Web of Science ®Google Scholar
• van HoevenKHFactorSMA comparison of the pathologic spectrum of hypertensive, diabetic, and hypertensive-diabetic heart diseaseCirculation1990828488552394006
   PubMed Web of Science ®Google Scholar
• WaagsteinFHjalmarsonAVarnauskasEEffect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathyBr Heart J1975371022361191416
   PubMedGoogle Scholar
• WikstrandJHjalmarsonAWaagsteinFDose of metoprolol CR/XL and clinical outcomes in patients with heart failure: analysis of the experience in metoprolol CR/XL randomized intervention trial in chronic heart failure (MERIT-HF)J Am Coll Cardiol2002404919812142116
   PubMed Web of Science ®Google Scholar
• YoonYSUchidaSMasuoOProgressive attenuation of myocardial vascular endothelial growth factor expression is a seminal event in diabetic cardiomyopathy: restoration of microvascular homeostasis and recovery of cardiac function in diabetic cardiomyopathy after replenishment of local vascular endothelial growth factorCirculation200511120738515851615
   PubMed Web of Science ®Google Scholar
• ZarichSWNestoRWDiabetic cardiomyopathyAm Heart J19891181000122683698
   PubMed Web of Science ®Google Scholar